Revolutionizing Cancer Treatment: Callio Therapeutics Launches with $187 Million to Develop Advanced Multi-Payload Antibody-Drug Conjugates March 3, 2025
Callio Therapeutics: Revolutionizing Cancer Treatment with $187 Million Funding for Innovative Multi-Payload Antibody-Drug Conjugates March 3, 2025
Hope on the Horizon: Leqembi Moves Closer to Approval in Europe for Alzheimer’s Treatment March 3, 2025
European Regulators Move Closer to Approving Leqembi: A Breakthrough in Alzheimer’s Treatment March 3, 2025
Leqembi’s Path to European Approval: A Promising Advance in Alzheimer’s Treatment Amid Safety Considerations March 3, 2025
Leqembi’s Path to European Approval: A Milestone in Alzheimer’s Treatment Amid Safety Concerns March 2, 2025
Leqembi: A Breakthrough Alzheimer’s Treatment Poised for European Approval Amidst Genetic Insights March 2, 2025
